Angiotensin II-Receptor Antagonists: An Overview

Raquel Dina and Mahtab Jafari

Disclosures

Am J Health Syst Pharm. 2000;57(13) 

In This Article

Conclusion

Angiotensin-II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Currently, AT-II-receptor antagonists are used either as monotherapy in patients who cannot tolerate ACE inhibitors or in combination with hydrochlorothiazide or other antihypertensive agents.

[a] Valsartan data on file. Novartis, East Hanover, NJ; 1996.

[b] Chando TJ, Everett DW, Kahle AD et al. Biotransformation of irbesartan in man. Data on file. Bristol-Myers Squibb, Princeton, NJ; 1997.

[c] Telmisartan data on file. Boehringer Ingelheim, Ridgefield, CT; 1998.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....